Mylan MYL

  1. All
  2. Commentary
  3. Headlines
    1. Teva discloses 1.35 pct stake in target Mylan

      Headlines

      Wed, 27 May 2015

      May 27 (Reuters) - Teva Pharmaceutical Industries Ltd disclosed a 1.35 percent interest in Mylan NV , saying the purchase underscored its commitment to buy Mylan as soon as possible.

    2. Endo Builds Generic Business Through Acquisition of Par Pharmaceuticals

      Commentary

      Sun, 17 May 2015

      we still think Par appears considerably disadvantaged, even following a combination with Endo (Peers such as Teva, Mylan , Dr. Reddy’s, and Hikma are more vertically integrated and run lower cost operations). Endo's management has

    3. Mylan chairman said to consider Perrigo sweeteners to make deal -Bloomberg

      Headlines

      Mon, 11 May 2015

      May 11 (Reuters) - Mylan NV's Chairman Robert Coury said he may sweeten the company's offer for Perrigo Co Plc by adding terms that will reduce risk to Perrigo's shareholders, sources told Bloomberg on Monday.

    4. Mayne Pharma Takes Full Control of Oxycodone and Methamphetamine in the United States

      Commentary

      Wed, 6 May 2015

      ended its distribution agreement with Mylan for Oxycodone products (Oxycodone ..... Oxycodone products distributed by Mylan contributed approximately USD 7 million ..... largely reflecting a lack of support by Mylan in first-half fiscal 2015, saw Oxycodone

    5. Mylan Posts Decent First Quarter as M&A Situation Remains Uncertain

      Commentary

      Wed, 6 May 2015

      Mylan ’s first-quarter results of 9% revenue and 6 ..... s assets become integrated. We think Mylan ’s narrow moat rating remains intact, but ..... creates a meaningful headwind. Additionally, Mylan ’s inability to receive FDA approval of its

    6. UPDATE 2- Mylan says can close Perrigo deal by year end, reports profit

      Headlines

      Tue, 5 May 2015

      May 5 (Reuters) - Generic drugmaker Mylan NV, at the center of a high-stakes, three-way takeover battle, said on Tuesday it is fully committed to acquiring Ireland-based Perrigo Co and believes it...

    7. BRIEF- Mylan confident it can close Perrigo deal by year end

      Headlines

      Tue, 5 May 2015

      May 5 (Reuters) - Mylan Sees q2 adjusted eps $0.86 to $0.90

    8. Mylan reports profit, maintains commitment to acquire Perrigo

      Headlines

      Tue, 5 May 2015

      May 5 (Reuters) - Generic drugmaker Mylan NV, at the center of a high-stakes, three-way takeover battle, on Tuesday reported slightly higher-than-expected first-quarter profit and said it was "steadfast" in its commitment to acquire Ireland-based Perrigo Co.

    9. UPDATE 2-Teva lifts 2015 earnings forecast as pursues Mylan bid

      Headlines

      Thu, 30 Apr 2015

      * Teva shares down 1.2 pct in New York (Adds comments on Mylan , Copaxone, analyst, shares)

    10. BRIEF-Teva CEO on Mylan bid

      Headlines

      Thu, 30 Apr 2015

      April 30 (Reuters) - Teva Pharmaceutical Industries TEVA.N> CEO Erez Vigodman says:

    « Prev12345Next »
    Content Partners